Automated closed-cell production platform solves dilemma of industrial-scale manufacturing for mesenchymal stromal cell-based therapy

• Yirui Feng,
• Bin Wang

Affiliations

Yirui Feng

Clinical Stem Cell Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210000, China; School of Life Science, Nanjing University, Nanjing, 210000, China

Bin Wang

Clinical Stem Cell Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210000, China; Corresponding author.